The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer
Abstract
Although small interfering RNA (siRNA) holds great therapeutic promise, its delivery to the disease site remains a paramount obstacle. In this study, we tested whether brain endothelial cell-derived exosomes could deliver siRNA across the blood-brain barrier (BBB) in zebrafish. Natural exosomes were isolated from brain endothelial bEND.3 cell culture media and vascular endothelial growth factor (VEGF) siRNA was loaded in exosomes with the assistance of a transfection reagent. While fluorescence-activated cell flow cytometry and immunocytochemistry staining studies indicated that wild-type exosomes significantly increased the uptake of fluorescence-labeled siRNA in the autologous brain endothelial cells, decreased fluorescence intensity was observed in the cells treated with the tetraspanin CD63 antibody-blocked exosome-delivered formulation (p < 0.05). In the transport study, exosomes also enhanced the permeability of rhodamine 123 in a co-cultured monolayer of brain endothelial bEND.3 cell and astrocyte. Inhibition at the expression of VEGF RNA and protein levels was observed in glioblastoma-astrocytoma U-87 MG cells treated with exosome-delivered siRNAs. Imaging results showed that exosome delivered more siRNAs across the BBB in Tg(fli1:GFP) zebrafish. In a xenotransplanted brain tumor model, exosome-delivered VEGF siRNAs decreased the fluorescence intensity of labeled cancer cells in the brain of zebrafish. Brain endothelial cell-derived exosomes could be potentially used as a natural carrier for the brain delivery of exogenous siRNA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some natural cell membranes such as exosomes without any functionalization have ability to cross the BBB.”
From The blood–brain barrier: Structure, regulation and drug delivery (2023) · cites this paper as [361]
Citations
Cites
The zebrafish book : a guide for the laboratory use of zebrafish (Danio rerio)
Westerfield, M. (1995) · Medical Entomology and Zoology · Cited by 6,813
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Exosomes – vesicular carriers for intercellular communication
Simons, M., & Raposo, G. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.03.007 · Cited by 2,410
Vlassov, A. V., Magdaleno, S. M., Setterquist, R. A., & Conrad, R. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.03.017 · Cited by 1,984
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W. E., Miller, D., & Zhang, H. (2010) · Molecular Therapy · doi:10.1038/mt.2010.105 · Cited by 1,579
Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R. C., Ju, S., Mu, J., Zhang, L., Steinman, L., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.164 · Cited by 1,356
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H., Maraganore, J. M., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,223
Pardridge, W. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.013 · Cited by 1,191
Jang, S. C., Kim, O. Y., Yoon, C. M., Choi, D., Roh, T., Park, J., Nilsson, J. A., Lötvall, J. O., Kim, Y., & Gho, Y. S. (2013) · ACS Nano · doi:10.1021/nn402232g · Cited by 1,037
Yang, T., Martin, P. B., Fogarty, B., Brown, A. H., Schurman, K., Phipps, R. J., Yin, V. P., Lockman, P. R., & Bai, S. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1593-y · Cited by 980
Self-citationApproaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 829
The Zebrafish Book : A Guide for the Laboratory Use of Zebrafish
Westerfield, M. (2000) · Medical Entomology and Zoology · Cited by 783
Exosomes as intercellular signalosomes and pharmacological effectors
Record, M., Subra, C., Silvente‐Poirot, S., & Poirot, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.02.011 · Cited by 550
Exosomes for drug delivery—A novel application for the mesenchymal stem cell
Lai, R. C., Yeo, R. W. Y., Tan, K. H., & Lim, S. K. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.08.008 · Cited by 546
Exosome mimetics: a novel class of drug delivery systems
Schiffelers, R. M., Kooijmans, S. A. A., Vader, P., van Dommelen, & van Solinge, W. W. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29661 · Cited by 531
Systemic exosomal siRNA delivery reduced alpha‐synuclein aggregates in brains of transgenic mice
Cooper, J. A. D., Wiklander, O. P. B., Nordin, J. Z., Al‐Shawi, R., Wood, M. J. A., Vithlani, M., Schapira, A. H. V., Simons, J. P., Andaloussi, S. E., & Alvarez‐Erviti, L. (2014) · Movement Disorders · doi:10.1002/mds.25978 · Cited by 521
Exosomes are natural carriers of exogenous siRNA to human cells in vitro
Shtam, T. A., Kovalev, R. A., Varfolomeeva, E. Y., Makarov, E. M., Kil, Y. V., & Filatov, M. V. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-88 · Cited by 499
Liposomal siRNA nanocarriers for cancer therapy
Özpolat, B., Sood, A. K., & Lopez‐Berestein, G. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.008 · Cited by 455
Functional and developmental analysis of the blood–brain barrier in zebrafish
Jeong, J.-Y., Kwon, H.-B., Ahn, J.-C., Kang, D., Kwon, S., Park, J. A., & Kim, K.-W. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.10.043 · Cited by 391
Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders
Schneider, A., & Simons, M. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1428-2 · Cited by 301
Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse
Liu, Y., Li, D., Liu, Z., Zhou, Y., Chu, D., Li, X., Jiang, X., Hou, D., Chen, X., Chen, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep17543 · Cited by 288
Exosomes as nucleic acid nanocarriers
van den Boorn, J. G., Daßler, J., Coch, C., Schlee, M., & Hartmann, G. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.011 · Cited by 285
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
Fan, Y., & Moon, J. J. (2015) · Vaccines · doi:10.3390/vaccines3030662 · Cited by 278
Lakhal, S., & Wood, M. J. A. (2011) · BioEssays · doi:10.1002/bies.201100076 · Cited by 271
A novel transgenic zebrafish model for blood-brain and blood-retinal barrier development
Xie, J., Farage, E., Sugimoto, M., & Anand‐Apte, B. (2010) · BMC Developmental Biology · doi:10.1186/1471-213x-10-76 · Cited by 233
Li, G., Simon, M. J., Cancel, L. M., Shi, Z., Ji, X., Tarbell, J. M., Morrison, B., & Fu, B. M. (2010) · Annals of Biomedical Engineering · doi:10.1007/s10439-010-0023-5 · Cited by 232
Exosome target cell selection and the importance of exosomal tetraspanins: a hypothesis
Rana, S., & Zöller, M. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390559 · Cited by 224
Growth and Maturation in the Zebrafish, Danio Rerio : A Staging Tool for Teaching and Research
Singleman, C., & Holtzman, N. G. (2014) · Zebrafish · doi:10.1089/zeb.2014.0976 · Cited by 224
Haqqani, A. S., Delaney, C. E., Tremblay, T., Sodja, C., Sandhu, J. K., & Stanimirovic, D. B. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-4 · Cited by 200
VEGF-VEGFR Signals in Health and Disease
Shibuya, M. (2014) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2013.113 · Cited by 183
Characterization of Rhodamine-123 as a Tracer Dye for Use In In vitro Drug Transport Assays
Forster, S. L., THUMSER, A. E. A., Hood, S. R., & Plant, N. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033253 · Cited by 175
The zebrafish as a tool to identify novel therapies for human cardiovascular disease
Asnani, A. H., & Peterson, R. T. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016170 · Cited by 169
Gururangan, S., Fangusaro, J., Poussaint, T. Y., McLendon, R. E., Onar‐Thomas, A., Wu, S., Packer, R. J., Banerjee, A., Gilbertson, R. J., Fahey, F. H., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not154 · Cited by 162
Recent Advances in Nanoparticle-Mediated siRNA Delivery
Williford, J., Wu, J., Ren, Y., Archang, M. M., Leong, K. W., & Mao, H. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105119 · Cited by 161
Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy
Mishra, D., Hubenak, J. R., & Mathur, A. B. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34642 · Cited by 132
A Novel Zebrafish Xenotransplantation Model for Study of Glioma Stem Cell Invasion
Yang, X., Cui, W., Ai, G., Xu, C. S., Yu, S., Li, T., Cui, Y., Zhang, X., & Bian, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061801 · Cited by 128
Ghosh, Y. K., Visweswariah, S. S., & Bhattacharya, S. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01558-1 · Cited by 127
VEGF Inhibitors in Cancer Therapy
Cardones, A. R., & Bañez, L. L. (2005) · Current Pharmaceutical Design · doi:10.2174/138161206775201910 · Cited by 115
Bai, S., Yang, T., Abbruscato, T. J., & Ahsan, F. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21031 · Cited by 104
Self-citationVEGF Signaling in Cancer Treatment
Sia, D., Alsinet, C., Newell, P., & Villanueva, A. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990590 · Cited by 90
Gidwani, M., & Singh, A. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140508122558 · Cited by 73
Zebrafish as a Model to Study Drug Transporters at the Blood–Brain Barrier
Umans, R. A., & Taylor, M. R. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.168 · Cited by 65
Kubowicz, P., Żelaszczyk, D., & Pękala, E. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990118 · Cited by 63
Therapeutic face of RNAi:in vivochallenges
Borna, H., İmani, S., Iman, M., & Jamalkandi, S. A. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.983070 · Cited by 59
Gururangan, S., Fangusaro, J., Poussaint, T. Y., Onar‐Thomas, A., Gilbertson, R. J., Vajapeyam, S., Gajjar, A. J., Goldman, S., Friedman, H. S., Packer, R. J., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos213 · Cited by 59
Novel models for assessing blood–brain barrier drug permeation
Geldenhuys, W. J., Allen, D. D., & Bloomquist, J. R. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.677433 · Cited by 47
Delivery of Small Interfering RNAs to Cells via Exosomes
Wahlgren, J., Statello, L., Skogberg, G., Telemo, E., & Valadi, H. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3112-5_10 · Cited by 40
Zebrafish xenotransplantation as a tool for in vivo cancer study
Zhang, B., Xuan, C., Ji, Y., Zhang, W., & Wang, D. (2015) · Familial Cancer · doi:10.1007/s10689-015-9802-3 · Cited by 37
The Promise of Zebrafish as a Chemical Screening Tool in Cancer Therapy
Xie, X., Ross, J., Cowell, J. K., & Teng, Y. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.73 · Cited by 20
In vitroevaluation of optimized liposomes for delivery of small interfering RNA
Yang, T., Bantegui, T., Pike, K., Bloom, R., Phipps, R. J., & Bai, S. (2014) · Journal of Liposome Research · doi:10.3109/08982104.2014.907306 · Cited by 19
Self-citation
Cited by
Sorted by citations
Exosomes: biogenesis, biologic function and clinical potential
Zhang, Y., Liu, Y., Liu, H., & Tang, W. H. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0282-2 · Cited by 2,119
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
“Some natural cell membranes such as exosomes without any functionalization have ability to cross the BBB. 335,361 The delivery ef fi ciency is mainly dependent on the lipid membrane and the active proteins which mediate the internalization between exosomes and target cells.”
BackgroundExtracellular vesicles in cancer — implications for future improvements in cancer care
Xu, R., Rai, A., Chen, M., Suwakulsiri, W., Greening, D. W., & Simpson, R. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0036-9 · Cited by 1,472
Current Strategies for Brain Drug Delivery
Dong, X. (2018) · Theranostics · doi:10.7150/thno.21254 · Cited by 954
“The exosomes facilitated siRNA to cross the BBB and inhibited VEGF in xenotransplanted zebrafish bearing brain tumors [58].”
BackgroundDesign strategies and application progress of therapeutic exosomes
Liu, C., & Su, C. (2019) · Theranostics · doi:10.7150/thno.30853 · Cited by 424
Metadata
- Authors
- Yang, T., Fogarty, B., LaForge, B., Aziz, S., Pham, T., Lai, L., & Bai, S.
- Affiliations
- Husson University (US)
- Nova Southeastern University (US)
- Corresponding author
- Bai, Shuhua
- Venue
- The AAPS Journal
- Published
- 2016-11-23
- Volume
- 19
- Issue
- 2
- Pages
- 475-486
- ISSN
- 1550-7416 (ISSN-L)
- OpenAlex
- W2552099798
- Cited by
- 204
- References
- 52
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 24 · 2023: 27 · 2022: 29 · 2021: 40 · 2020: 22 · 2019: 16 · 2018: 11 · 2017: 5
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The AAPS Journal (publishedVersion)
- PubMed (publishedVersion)
- NSUWorks (Nova Southeastern University) (submittedVersion)
- Funders
- Husson University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- exosomes, siRNA delivery, vascular endothelial growth factor, blood-brain barrier, brain endothelial cells, glioblastoma, brain cancer, CD63, bEnd.3 cells, zebrafish xenograft, U87 cells, astrocytes, tetraspanins
- MeSH terms
- Animals, Astrocytes, Blood-Brain Barrier, Brain, Brain Neoplasms, Humans, Transfection, Zebrafish, Gene Transfer Techniques, Coculture Techniques, RNA, Small Interfering, Vascular Endothelial Growth Factor A, Endothelial Cells, Cell Line, Tumor, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
